Young patients with advanced Hodgkin's lymphoma, a cancer of the lymphatic system, now have a better chance of having their ...

Stage 3 lymphoma is a lymphatic cancer that has spread to lymph nodes above and below the diaphragm. Learn its symptoms, ...

WEDNESDAY, June 25, 2025 (HealthDay News) -- For women with breast cancer (BC), BRCA mutations are associated with increased risk of developing breast implant–associated anaplastic large cell ...

Along with PET, ctDNA offers novel benefits in identifying genetic subgroups and guiding treatment adjustments to assess acalabrutinib’s role in non-chemotherapy responders.

Novel lymphoma microenvironment profiles presage response to CAR T-cell therapy in large B-cell lymphoma.

In July 2020, Monjuvi in combination with lenalidomide received FDA approval for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise ...

During a live event, Priyanka Pophali, MD, MBBS, discussed CAR T-cell therapy referrals, timing, and challenges in relapsed ...

A panelist discusses how the shift from intravenous to oral AML therapies addresses significant quality-of-life concerns by eliminating the burden of spending 7 days per month in clinics for infusions ...

Treatment for non-Hodgkin lymphoma can depend on the type and stage. Learn more here.

Three major Mount Sinai research studies offer new hope for patients facing chronic lymphocytic leukemia (CLL), a rare type ...

New research reveals critical gaps in treatment for advanced non–small cell lung cancer (NSCLC), emphasizing the need for ...